Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world Study of Camrelizumab Alone or in Combination With Apatinib/Chemotherapy for Advanced Gastric Cancer

NCT06485271 is registered in ClinicalTrials.gov with Changzhi People's Hospital Affiliated to Changzhi Medical College as lead sponsor.

NCT NCT06485271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06485271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world Study of Camrelizumab Alone or in Combination With Apatinib/Chemotherapy for Advanced Gastric Cancer
Lead sponsor
Changzhi People's Hospital Affiliated to Changzhi Medical College
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2023
Completion date
October 31, 2026
Enrollment
504 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer, pd-1 immunotherapy, rws